Treatment discontinuation effects on bone turnover and BMD with risedronate

被引：0
|
作者：
Watts, N
Olszynski, WP
McKeever, CD
Grauer, A
Chines, A
机构：
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
[2] Midtown Med Ctr, Saskatoon, SK, Canada
[3] McKeever Orthoped Clin, Houston, TX USA
[4] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
BONE | 2004年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [41] Effects of testosterone replacement therapy on BMD and bone turnover in young hypogonadal males.
    Gupta, SK
    Deb, P
    Godbole, MM
    Mithal, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S548 - S548
  • [42] Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate
    Khedr, Naglaa F.
    El-Ashmawy, Nahla E.
    El-Bahrawy, Hoda A.
    Haggag, Ali A.
    El-Abd, Eman E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (05) : 526 - 534
  • [43] Comparative study of bone turnover and BMD responses to treatment with risedronate, vitamin D, or vitamin K in Japanese osteoporosis patients: Results of a 24-week interim analysis.
    Iwata, H
    Yamada, S
    Takagi, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S443 - S443
  • [44] Rapid resolution of the reduction of bone turnover markers after discontinuation of risedronate in postmenopausal women with osteoporosis previously treated for 2 years.
    Brown, JP
    Yuen, SY
    Banville, C
    Picard, S
    Jean, S
    Adachi, JD
    Kendler, DL
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (07) : 1430 - 1430
  • [45] CHANGE IN BONE MINERAL DENSITY (BMD) OR BONE TURNOVER MARKERS (BTM) DID NOT PREDICT RISK OF VERTEBRAL FRACTURE AFTER DISCONTINUATION OF ALENDRONATE IN THE FLEX STUDY
    Chang, S.
    Bauer, D.
    Black, D.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S377 - S377
  • [46] Effect of one year DHEA treatment or placebo on bone mineral density (BMD) and bone turnover: The DHEage study
    Cormier, C
    Souberbielle, JC
    Raison, J
    Kindermans, C
    Forette, F
    Baulieu, EE
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S176 - S176
  • [47] Oral risedronate treatment in men with osteoporosis: Effects on bone quality and bone remodeling.
    Recker, R.
    Eusebio, R.
    Xu, S.
    Boonen, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S111 - S111
  • [48] MARKERS OF BONE TURNOVER IN HYPERTHYROIDISM AND THE EFFECTS OF TREATMENT
    GARNERO, P
    VASSY, V
    BERTHOLIN, A
    RIOU, JP
    DELMAS, PD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04): : 955 - 959
  • [49] Risedronate increases BMD in anorexia nervosa
    Joana Osório
    Nature Reviews Endocrinology, 2011, 7 (8) : 437 - 437
  • [50] Trabecular bone turnover is reestablished sooner in ovariectomized rats after withdrawal of treatment with risedronate vs alendronate
    Fuchs, RK
    Phipps, RJ
    Burr, DB
    BONE, 2006, 38 (03) : S50 - S50
12345